Home/Filings/4/0001104659-19-031178
4//SEC Filing

Khwaja Omar 4

Accession 0001104659-19-031178

CIK 0001640266other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 6:44 PM ET

Size

8.5 KB

Accession

0001104659-19-031178

Insider Transaction Report

Form 4
Period: 2019-05-20
Khwaja Omar
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-05-20+170,000170,000 total
    Exercise: $21.86Exp: 2029-05-20Common Stock (170,000 underlying)
  • Award

    Common Stock

    2019-05-20+30,00030,000 total
Footnotes (3)
  • [F1]This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
  • [F2]Consists of shares of common stock underlying a restricted stock unit ("RSU") award. Each RSU represents the right to receive one share of common stock, par value $0.001 per share, of the Company (the "Common Stock") upon vesting. The vesting commencement date of the RSU award is May 20, 2019. The RSU award vests over three years, with 33.33% of the shares of Common Stock underlying the award vesting upon the one-year anniversary of the vesting commencement date of such award and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued employment by the Company and other terms and conditions set forth in the applicable RSU agreement.
  • [F3]The vesting commencement date of the option is May 20, 2019. The option vests over four years, with 25% of the shares of Common Stock underlying the option vesting upon the one-year anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment by the Company and other terms and conditions set forth in the applicable option agreement.

Documents

1 file

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0001776393

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:44 PM ET
Size
8.5 KB